“The chimpanzees would stagger and stumble, vomit, and have diarrhea,” he said. “Sometimes they’d go to bed healthy and be dead in the morning.”
After several years spent screening DNA and samples from the primates, Goldberg’s graduate student Leah A. Owens isolated a bacterium that was in 68% of the samples from sick chimpanzees.
Under a microscope, what she found on her slide — which reportedly resembled a four-leaf clover — looked like that of the genus Sarcina — which, at the time, only included two other known species.
The bacterium Owens found is now called Sarcina troglodytae, after the species of chimpanzee it infects — Pan troglodytes.
The newfound disease it causes has been named Epizootic Neurologic and Gastroenteric Syndrome (ENGS).
There are still a lot of unknown variables. For example, while it is known that the bacterium can live in soil, it is not understood how the Tacugama chimpanzees ingested it, why there is a prevalence in the month of March, and whether or not the bacterium alone causes the illness.
The disease has a fatality rate of 100%.
While ENGS has not infected any humans — the Sarcina genus had found only 44 cases of human infection — humans and chimpanzees share about 99% of their genomes, including gut bacteria.
Although the biggest threat, according to Science Magazine, remains that ENGS will spread to wild chimpanzees or other sanctuaries, Goldberg told The Milwaukee Journal Sentinel on Wednesday that he was monitoring the pathogen.
“There are very few pathogens that infect chimpanzees without infecting humans and very few pathogens that infect humans without infecting chimpanzees,” he said.